Biotech3 years ago
Grifols Announces a Profit of €3.3 Million After the First Quarter Losses
Grifols is a listed Catalan pharmaceutical company. The company's activity focuses on the research, development, manufacturing, and marketing of products derived from plasma (blood products), intravenous therapy...